JAMP-MONTELUKAST 10mg: may contain foreign fragments of pink candesartan tablets
Last updated
Summary
Product
JAMP-MONTELUKAST 10mg
Issue
Health products - Contamination
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| JAMP | JAMP-MONTELUKAST 10mg | DIN 02391422 | Tablet | MONTELUKAST SODIUM 10mg | AT240486A |
Issue
The affected lot may contain foreign fragments of pink candesartan tablets.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP Pharma Corporation 1310 Rue Nobel, Boucherville,QC, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-77328
Get notified
Receive notifications for new and updated recalls and alerts by category.